Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1998
11/12/1998CA2288773A1 Use of oligosaccharides for the treatment of connective tissues
11/12/1998CA2288759A1 Cox-2 selective carprofen for treating pain and inflammation in dogs
11/12/1998CA2288693A1 Method of improving disturbed behavior and elevating mood in humans
11/12/1998CA2288662A1 Indole derivatives having combined 5ht1a, 5ht1b and 5ht1d receptor antagonist activity
11/12/1998CA2288640A1 Enzymatic nucleic acids: synthesis, selection and use
11/12/1998CA2288639A1 Aplidine as an l-type calcium channel enhancer
11/12/1998CA2288333A1 Amidine derivatives as inhibitors of nitric oxide synthase
11/12/1998CA2288330A1 Benzoyl amino acid derivatives useful as inhibitors of protein isoprenyl tranferases
11/12/1998CA2288149A1 N-methyl-d-aspartate (nmda) receptor blockers for the prevention of atherosclerosis
11/12/1998CA2288017A1 Methods for eosinophil depletion and compositions therefor
11/12/1998CA2287999A1 Compounds
11/12/1998CA2287981A1 Nitric oxide carriers based on polyazamacrocycle complexes
11/12/1998CA2287929A1 Tricyclic pyridone analogues as gaba-a receptor ligands
11/12/1998CA2287924A1 4-aza-steroids as inhibitors of testosterone-5-alpha-reductase
11/12/1998CA2287913A1 Substituted tetrahydro isoquinolines as modulators of dopamine d3 receptors
11/12/1998CA2286341A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
11/11/1998EP0877091A1 Antifungal substances be-49385 and process for producing the same
11/11/1998EP0877089A1 HMG-CoA reductase inhibitor preparation process
11/11/1998EP0877083A1 A novel human G-protein coupled receptor (HCEPT09)
11/11/1998EP0877026A1 Substituted 6-r-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
11/11/1998EP0877025A1 Substituted 6-h-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
11/11/1998EP0877024A1 Substituted 6-h-1,3,4-thiadiazine-2-amines, the use thereof as an aesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
11/11/1998EP0877022A1 Synthesis of the sulfonylpyrimidine derivatives with anticancer activity
11/11/1998EP0877019A1 Substituted diaminocarboxylic acid
11/11/1998EP0877018A1 Sulfonylaminocarboxylic acids
11/11/1998EP0876818A2 Agent for treating neuro-degenerative disorders
11/11/1998EP0876817A1 Remedy for keratoconjunctival diseases
11/11/1998EP0876815A1 "Drug delivery system for two or more active substances"
11/11/1998EP0876813A1 Composition containing a microorganism culture medium
11/11/1998EP0876613A1 Treatment and diagnosis of infections due to helicobacter pylori
11/11/1998EP0876612A1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules
11/11/1998EP0876507A2 MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C - PP2C$g(a) - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION
11/11/1998EP0876498A1 Mixture of recombinant vaccinia vectors as polygeur vaccines for hiv
11/11/1998EP0876486A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof
11/11/1998EP0876485A2 NOVEL CREBa ISOFORM
11/11/1998EP0876483A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor
11/11/1998EP0876482A1 Il-13 receptor polypeptide
11/11/1998EP0876398A1 Induction of immune response against desired determinants
11/11/1998EP0876393A1 21-(2-oxo-tetrahydrofuran)-thio pregnane derivatives, a process for their production and pharmaceutical compositions containing them
11/11/1998EP0876392A1 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives
11/11/1998EP0876389A1 Therapeutic compounds
11/11/1998EP0876388A1 Tricyclic erythromycin derivatives
11/11/1998EP0876387A1 Method to improve the biological and antiviral activity of protease inhibitors
11/11/1998EP0876386A1 Water soluble antibiotics
11/11/1998EP0876379A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
11/11/1998EP0876378A1 3,4-DIHYDRO 1,2,4]THIADIAZINO 3,4-b]BENZOTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
11/11/1998EP0876376A1 Pyrido (3,2,1-ij)-1,3,4-benzoxadiazine
11/11/1998EP0876372A1 Heteroarylcarboxamide derivatives
11/11/1998EP0876371A1 Reverse-turn mimetics and methods relating thereto
11/11/1998EP0876369A1 2- 2- (2-HYDROXYETHYL)AMINO]ETHYL]-5- 2-METHYLAMINO)ETHYL]AMINO]INDAZOLO 4,3-gh]ISOQUINOLIN-6(2H)-ONE AS ANTITUMOR AGENT
11/11/1998EP0876368A1 Use of mono- or diketone tetracyclic derivatives, resulting novel compounds and therapeutical use thereof
11/11/1998EP0876367A1 Trans apovincaminic acid ester derivatives as drugs
11/11/1998EP0876366A2 Angiogenesis inhibiting pyridazinamines
11/11/1998EP0876365A1 Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors
11/11/1998EP0876364A2 Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
11/11/1998EP0876362A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
11/11/1998EP0876361A1 4,10$g(b)-DIACETOXY-2$g(a)-BENZOYLOXY-5$g(b),20-EPOXY-1-HYDROXY-9-OXO-19-NOR-CYCLOPROPA G]TAX-11-ENE-13$g(a)-YL (2R,3S)-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DIHYDRATE, AND METHOD FOR PREPARING SAME
11/11/1998EP0876359A1 (-) cis-6(s)-phenyl-5(r) 4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate
11/11/1998EP0876357A1 New quinoxalindione derivatives, their preparation and use in medicaments
11/11/1998EP0876356A1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
11/11/1998EP0876355A1 2-thioxo-imidazolidin-4-one derivatives and their use for increasing hdl cholesterol concentration
11/11/1998EP0876354A1 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives
11/11/1998EP0876353A1 Retroviral protease inhibiting compounds
11/11/1998EP0876352A1 Process
11/11/1998EP0876350A1 Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives
11/11/1998EP0876348A1 Salts of quinoline derivatives as nk3 antagonists
11/11/1998EP0876347A1 Quinoline derivatives
11/11/1998EP0876346A1 Antimalarial quinolin derivatives
11/11/1998EP0876345A1 Heterocyclic compounds as h+-atpases
11/11/1998EP0876343A1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases
11/11/1998EP0876337A2 New lh-rh antagonists with improved effectiveness
11/11/1998EP0876336A1 Azahexane derivatives as substrate isosters of retroviral asparate proteases
11/11/1998EP0876330A1 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity
11/11/1998EP0876166A1 Use of injectable or implantable biomaterials for filling or blocking lumens and voids of the body
11/11/1998EP0876160A2 Ligand directed enzyme prodrug therapy
11/11/1998EP0876158A1 Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms
11/11/1998EP0876157A1 Methods and compositions for passive immunotherapy
11/11/1998EP0876156A1 Compositions and methods for administering borrelia burgdorferi antigens
11/11/1998EP0876154A1 Using serine-proteases for acne and inflamed comedones
11/11/1998EP0876153A2 Medical use of proteases
11/11/1998EP0876152A1 Novel administration of thrombopoietin
11/11/1998EP0876149A1 Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase
11/11/1998EP0876148A1 Sphingolipids effective against bacteria, parasites, protozoans, fungi and viruses
11/11/1998EP0876147A1 Use of galanthamine in the preparation of novel drugs
11/11/1998EP0876146A1 Nucleoside analogs in combination therapy of herpes simplex infections
11/11/1998EP0876145A1 Taxane composition and method
11/11/1998EP0876144A2 Therapeutic anti-asthma agents containing selenium compounds
11/11/1998EP0876143A2 TUMOR NECROSIS FACTOR ALPHA (TNF-$g(a)) INHIBITING PHARMACEUTICALS
11/11/1998EP0876141A2 Preparations of non-steroidal analgesics
11/11/1998EP0876140A2 Improved concentrated injection and infusion solutions for intravenous administration
11/11/1998EP0876137A1 Compounds based on squalene and sphingolipids effective against bacteria, parasites, protozoa, fungi and viruses
11/11/1998EP0876131A1 Drug delivery compositions for improved stability of steroids
11/11/1998EP0876110A1 Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids
11/11/1998EP0800386B1 Transdermal system for the simultaneous delivery of a number of active principles
11/11/1998EP0776197B1 Oestradiol-containing transdermal therapeutic system comprising hydrophylic additives
11/11/1998EP0766570A4 Methods for treating respiratory disease
11/11/1998EP0759919B1 Azolidinediones as antihyperglycemic agents
11/11/1998EP0744940B1 Drugs, vaccines and hormones in polylactide coated microspheres
11/11/1998EP0739344B1 Antiparasitic pyrrolobenzoxazine compounds
11/11/1998EP0720609B1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins
1 ... 6582 6583 6584 6585 6586 6587 6588 6589 6590 6591 6592 6593 6594 6595 6596 6597 6598 6599 6600 6601 6602 ... 7860